Literature DB >> 33161524

Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation.

Vincenzo Livio Malavasi1, Elisa Fantecchi1, Virginia Tordoni1, Laura Melara1, Andrea Barbieri1, Marco Vitolo1,2, Gregory Y H Lip2,3, Giuseppe Boriani4.   

Abstract

Atrial fibrillation (AF) may progress from a non-permanent to a permanent form, and improvement in prediction may help in decision-making. In- and outpatients with non-permanent AF were enrolled in a prospective study and followed every 6 months. At baseline, 314 out of 523 patients (60%) had non-permanent AF (25.5% paroxysmal AF, 52.5% persistent, 2% first diagnosed AF). They were mostly males (188, 59.9%), median age 71 years [interquartile range (IQ) 62-77], median CHA2DS2VASc 3 (IQ 1-4), median HATCH score 1 (IQ 1-2). During a follow-up of 701 (IQ 437-902) days, 66 patients (21%) developed permanent AF. CHA2DS2VASc and HATCH scores were incrementally associated with AF progression (p for trend CHA2DS2VASc < 0.001, HATCH p = 0.001). Cox multivariable proportional hazard regression analysis showed that age [hazard ratio (HR) 1.042; 95%CI 1.005-1.080; p = 0.025], moderate-severe left atrial (LA) enlargement at echo (HR 2.072, 95%CI, 1.121-3.831; p = 0.020), antiarrhythmics drugs (HR 0.087, 95%CI 0.011-0.659, p = 0.018), EHRA score > 2 (HR 0.358, 95%CI 0.162-0.791, p = 0.011) and valvular disease (HR 2.196, 95%CI 1.072-4.499, p = 0.032) were significantly associated with AF progression. Adding "moderate-severe LA dilation" to clinical scores, eg. HATCH score (HATCH-LA) with 2 points (Cox multivariable regression analysis) improved prediction of AF progression vs. HATCH score (p = 0.0225). In patients without permanent AF, progression of AF was independently associated with age, LA dilation, AF symptoms severity, antiarrhythmic drugs and valvular disease. Adding LA dilation (moderate-severe volume increase) to clinical scores improved prediction of progression to permanent AF.
© 2020. Società Italiana di Medicina Interna (SIMI).

Entities:  

Keywords:  Atrial fibrillation; HATCH score; Left atrial dilation; Progression

Year:  2020        PMID: 33161524     DOI: 10.1007/s11739-020-02551-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  44 in total

1.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis.

Authors:  Cees B de Vos; Ron Pisters; Robby Nieuwlaat; Martin H Prins; Robert G Tieleman; Robert-Jan S Coelen; Antonius C van den Heijkant; Maurits A Allessie; Harry J G M Crijns
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.

Authors:  Cees B De Vos; Günter Breithardt; A John Camm; Paul Dorian; Peter R Kowey; Jean-Yves Le Heuzey; Lisa Naditch-Brûlé; Eric N Prystowsky; Peter J Schwartz; Christian Torp-Pedersen; William S Weintraub; Harry J Crijns
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

3.  Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.

Authors:  Thomas Vanassche; Mandy N Lauw; John W Eikelboom; Jeff S Healey; Robert G Hart; Marco Alings; Alvaro Avezum; Rafael Díaz; Stefan H Hohnloser; Basil S Lewis; Olga Shestakovska; Jia Wang; Stuart J Connolly
Journal:  Eur Heart J       Date:  2014-09-03       Impact factor: 29.983

4.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

Authors:  Charles R Kerr; Karin H Humphries; Mario Talajic; George J Klein; Stuart J Connolly; Martin Green; John Boone; Robert Sheldon; Paul Dorian; David Newman
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

5.  A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.

Authors:  Tatjana S Potpara; Goran R Stankovic; Branko D Beleslin; Marija M Polovina; Jelena M Marinkovic; Miodrag C Ostojic; Gregory Y H Lip
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

6.  Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.

Authors:  Hisashi Ogawa; Yoshimori An; Syuhei Ikeda; Yuya Aono; Kosuke Doi; Mitsuru Ishii; Moritake Iguchi; Nobutoyo Masunaga; Masahiro Esato; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Gregory Y H Lip; Masaharu Akao
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

7.  Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.

Authors:  Teresa S M Tsang; Marion E Barnes; Yoko Miyasaka; Stephen S Cha; Kent R Bailey; Grace C Verzosa; James B Seward; Bernard J Gersh
Journal:  Eur Heart J       Date:  2008-07-08       Impact factor: 29.983

8.  Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.

Authors:  Robby Nieuwlaat; Martin H Prins; Jean-Yves Le Heuzey; Panos E Vardas; Etienne Aliot; Massimo Santini; Stuart M Cobbe; Jos W M G Widdershoven; Leo H Baur; Samuel Lévy; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2008-04-07       Impact factor: 29.983

9.  Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis.

Authors:  Steffen Blum; Pascal Meyre; Stefanie Aeschbacher; Sebastian Berger; Chloé Auberson; Matthias Briel; Stefan Osswald; David Conen
Journal:  Heart Rhythm       Date:  2018-10-24       Impact factor: 6.343

Review 10.  Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Authors:  Hai Deng; Ying Bai; Alena Shantsila; Laurent Fauchier; Tatjana S Potpara; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2017-05-30       Impact factor: 5.460

View more
  3 in total

1.  Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation.

Authors:  Giuseppe Boriani; Saverio Iacopino; Giuseppe Arena; Paolo Pieragnoli; Roberto Verlato; Massimiliano Manfrin; Giulio Molon; Giovanni Rovaris; Antonio Curnis; Giovanni Battista Perego; Antonio Dello Russo; Maurizio Landolina; Marco Vitolo; Claudio Tondo
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21

Review 2.  Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.

Authors:  Giuseppe Boriani; Marco Vitolo; Igor Diemberger; Marco Proietti; Anna Chiara Valenti; Vincenzo Livio Malavasi; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 13.081

3.  Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation.

Authors:  Jacopo Francesco Imberti; Niccolò Bonini; Alberto Tosetti; Davide Antonio Mei; Luigi Gerra; Vincenzo Livio Malavasi; Andrea Mazza; Gregory Y H Lip; Giuseppe Boriani
Journal:  Biology (Basel)       Date:  2022-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.